Edward Morrow Atkinson Iii Vertex Pharmaceuticals Inc (VRTX) insider trading activity

Edward Morrow Atkinson Iii is EVP, Chief Technical Ops. Off. of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 15,972 shares of VRTX, which is worth approximately $7.2 Million. The most recent transaction as insider was on Jun 12, 2024, when has been sold 7,288 shares (Common Stock) at a price of $478.0 per share, resulting in proceeds of $3,483,664. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16K

0% 3M change

n/a 12M change

Total Value Held $7.2 Million

Edward Morrow Atkinson III Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 12 2024	SELL Open market or private sale	$3,483,664 $478.0 p/Share	7,288 Reduced 31.33%	15,972 Common Stock
Jun 11 2024	SELL Payment of exercise price or tax liability	$3,288,895 $481.96 p/Share	6,824 Reduced 22.68%	23,260 Common Stock
May 14 2024	BUY Grant, award, or other acquisition	-	14,112 Added 31.93%	30,084 Common Stock
Feb 26 2024	SELL Open market or private sale	$375,893 $425.7 p/Share	883 Reduced 5.24%	15,972 Common Stock
Feb 23 2024	SELL Payment of exercise price or tax liability	$714,180 $431.79 p/Share	1,654 Reduced 8.94%	16,855 Common Stock
Feb 21 2024	SELL Open market or private sale	$506,545 $421.77 p/Share	1,201 Reduced 6.09%	18,509 Common Stock
Feb 20 2024	SELL Open market or private sale	$337,052 $420.79 p/Share	801 Reduced 3.91%	19,710 Common Stock
Feb 20 2024	SELL Payment of exercise price or tax liability	$473,152 $420.58 p/Share	1,125 Reduced 5.2%	20,511 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$636,439 $424.01 p/Share	1,501 Reduced 6.49%	21,636 Common Stock
Feb 12 2024	SELL Open market or private sale	$383,679 $420.24 p/Share	913 Reduced 3.8%	23,137 Common Stock
Feb 09 2024	SELL Payment of exercise price or tax liability	$351,719 $422.74 p/Share	832 Reduced 3.34%	24,050 Common Stock
Feb 07 2024	BUY Grant, award, or other acquisition	-	4,743 Added 16.01%	24,882 Common Stock
Feb 06 2024	BUY Grant, award, or other acquisition	-	6,260 Added 23.71%	20,139 Common Stock

Also insider at

ETNB

89bio, Inc. Healthcare

EMA